CCDR: Volume 51-10/11/12, October/November/December 2025: Tuberculosis and Migration in Canada

CCDR

Table of contents

Advisory Committee Summary

Summary of the National Advisory Committee on Immunization (NACI) Statement: Recommendations on the use of pneumococcal vaccines in adults, including Pneu-C-21
E Wong, O Baclic, MI Salvadori, K Hildebrand on behalf of the National Advisory Committee on Immunization (NACI)

Implementation Science

Evaluating Canada’s initiative of enhanced screening for tuberculosis infection in migrants: Implementation lessons from Alberta
C Heffernan, A Jamro, ML Egedahl, R Long

Epidemiologic Study

Treatment of tuberculosis infection among immigrants in southern New Brunswick, Canada: A cross-sectional study
IC Shamputa, DTK Nguyen, H Mackenzie, DJ Gaudet, A Harquail, K Barker, D Webster

Surveillance

Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2024
EF Tran, A Gauthier, AN Davis, C Abalos, S Bonti-Ankomah

Survey Report

Trust in community as a predictor of public health measure adherence: Insights from a national Canadian survey
N Seeman, J Trent, K Murty

Case Report

Detection of non-travel-associated, ceftriaxone non-susceptible Neisseria gonorrhoeae FC428-like harbouring the mosaic penA60 allele in Ontario, Canada
AS Komorowski, A Eshaghi, J Burbidge, K Johnson, A Saunders, A Zygmunt, M Hasso, H Almohri, I Martin, SN Patel, V Tran

Infographic

Zoonoses
Public Health Agency of Canada

Page details

2025-12-12